922 related articles for article (PubMed ID: 16477396)
1. Report on the PQRI impurity characterization and quantification best practices survey.
Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
[No Abstract] [Full Text] [Related]
2. USP general chapter <797> pharmaceutical compounding-sterile preparations.
Hung JC
J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
[No Abstract] [Full Text] [Related]
3. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
Hung JC
J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
[No Abstract] [Full Text] [Related]
4. Drug product quality.
Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
[No Abstract] [Full Text] [Related]
5. Standardization of forensic drug analyses.
Frank RS; Gunn JW
J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
[No Abstract] [Full Text] [Related]
6. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
Hyde TD
Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
[TBL] [Abstract][Full Text] [Related]
7. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
Jimenez FA
Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
[No Abstract] [Full Text] [Related]
8. GMPs vs GCPs: United States Pharmacopeia General Chapters.
Allen LV
Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
[No Abstract] [Full Text] [Related]
9. GMPs vs GCPs: manufacturing and compounding definitions.
Allen LV
Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
[No Abstract] [Full Text] [Related]
10. Pharmaceutical analysis: key to drug quality and control.
Florey KG; Brewer GA
Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
[No Abstract] [Full Text] [Related]
11. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
12. Protecting consumers from counterfeit drugs.
FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838
[No Abstract] [Full Text] [Related]
13. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
Hippenmeier F
Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
[No Abstract] [Full Text] [Related]
14. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
[TBL] [Abstract][Full Text] [Related]
15. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
[No Abstract] [Full Text] [Related]
16. Securing the US pharmaceutical supply.
Somberg JC
Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
[No Abstract] [Full Text] [Related]
17. [Quality control in the pharmaceutical industry].
Bretscher E
Pharm Acta Helv; 1972; 47(11):664-75. PubMed ID: 4657535
[No Abstract] [Full Text] [Related]
18. Current good manufacturing practices for PET drug products in the United States.
Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
[No Abstract] [Full Text] [Related]
19. Assuring the quality of the nation's drugs. Interview by William E. Small.
Michels D
Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377
[No Abstract] [Full Text] [Related]
20. Public standards for drugs: reflections on their use by the professions and industry.
Miller LC
Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
